Status:
UNKNOWN
Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDI
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Hepatocellular Carcinoma
Hepatitis B
Eligibility:
All Genders
Brief Summary
Hepatocellular carcinoma (HCC) has been the leading cause of cancer death in Taiwan. Though Alpha-fetoprotein (AFP) and des-γ-carboxy prothrombin(DCP) are used as the tumor markers for diagnosis of HC...
Detailed Description
Hepatocellular carcinoma (HCC) has been the leading cause of cancer death in Taiwan. Above 6000-8000 people died of this cancer every year in Taiwan. Though regular sonographic examination can early d...
Eligibility Criteria
Inclusion
- Clinical diagnosis of hepatocellular carcinoma
- Clinical diagnosis of hepatitis B
- Clinical diagnosis of hepatitis C
Exclusion
- N/A
Key Trial Info
Start Date :
August 1 2004
Trial Type :
OBSERVATIONAL
End Date :
May 1 2005
Estimated Enrollment :
230 Patients enrolled
Trial Details
Trial ID
NCT00154531
Start Date
August 1 2004
End Date
May 1 2005
Last Update
December 20 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan